Hyperbaric Treatment of Central Retinal Artery Occlusion

Hyperbaric Treatment of Central Retinal Artery Occlusion

Central retinal artery occlusion (CRAO) is a relatively rare but potentially devastating ocular emergency. Patients present with sudden, painless monocular vision loss. The prognosis for visual recovery is poor, and until recently, no treatment could restore any degree of functional vision to the affected eye. Central retinal artery occlusion leads to retinal hypoxia, and the retinal tissue is incredibly intolerant of hypoxia. In 2006, hyperbaric oxygen therapy was approved for treating central retinal artery occlusion. However, it remains a vastly underutilized modality, partially due to insufficient availability and awareness in the ophthalmology community. This activity describes the pathophysiology, evaluation, and management of central retinal artery occlusion and highlights the role of the interprofessional team in caring for affected patients.

  • Provider:StatPearls, LLC
  • Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/31601
  • Start Date: 2023-09-01 05:00:00
  • End Date: 2023-09-01 05:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
    Nursing: 1.0 hours
    Pharmacy: 1.0 hours
  • MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
    ABPATH - 1.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
    ABS - 1.0 Point; Credit Type(s): Self-Assessment (ABS)
  • Commercial Support: No
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: Variable
  • Measured Outcome: Learner Knowledge, Learner/Team Competence
  • Provider Ship: Directly Provided
  • Registration: Open to all
  • Specialty: All Practice Areas (e.g. ethics), General Surgery
«
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.